Efficacy and Safety of Ifosfamide and Mesna in Metastatic Castration-Resistant Prostate Cancer after Taxane-Based Chemotherapy and Novel Hormonal Therapy Failure
Ifosfamide and mesna showed appreciable efficacy and manageable safety profiles in heavily treated patients with mCRPC.
Authors
- Ji Eun Heo (ORCID: https://orcid.org/0000-0002-4184-8468)
- D. Kim (ORCID: https://orcid.org/0000-0001-8980-2664)
- Chung Lee (ORCID: https://orcid.org/0000-0003-0855-4553)
- Minsun Jung (ORCID: https://orcid.org/0000-0002-8701-4282)
- Seung‐Hoon Beom (ORCID: https://orcid.org/0000-0001-7036-3753)
- Woong Kyu Han (ORCID: https://orcid.org/0000-0002-2527-4046)
- Sang Joon Shin (ORCID: https://orcid.org/0000-0001-5350-7241)
- Eun Sil Baek
- Won Sik Ham (ORCID: https://orcid.org/0000-0003-2246-8838)
- Jongjin Yoon (ORCID: https://orcid.org/0000-0003-4733-7658)
- Young Deuk Choi (ORCID: https://orcid.org/0000-0002-8545-5797)
- Sang‐Woo Kim (ORCID: https://orcid.org/0000-0002-0079-5806)
- Jong‐Soo Lee (ORCID: https://orcid.org/0000-0001-5119-0711)
- Hyunho Han (ORCID: https://orcid.org/0000-0002-1221-5733)
- Y.J. Ko (ORCID: https://orcid.org/0009-0004-5157-5063)
- Chang Gon Kim
Institutions
- Cancer Research Institute (US)
- Yonsei University (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-06-09
- DOI
- https://doi.org/10.4143/crt.2025.155
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Yonsei University
- Ministry of Science and ICT, South Korea
- Yonsei University College of Medicine